Skip to main content
SpringerLink
Log in

Clinical Usefulness of 5-FU Metabolic Enzymes as Predictive Markers of Response to Chemotherapy in Colorectal Cancer

  • Reply, Letter to the Editor
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Shigeta K, Ishii Y, Hasegawa H et al (2014) Evaluation of 5-fluorouracil metabolic enzymes as predictors of response to adjuvant chemotherapy outcomes in patients with stage II/III colorectal cancer: a decision-curve analysis. World J Surg 38:3248–3256. doi:10.1007/s00268-014-2738-1

    Article  PubMed  Google Scholar 

  2. Boni V, Bitarte N, Cristobal I et al (2010) miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther 9:2265–2275

    Article  CAS  PubMed  Google Scholar 

  3. Paradiso A, Simone G, Petroni S et al (2000) Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82:560–567

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Sadahiro S, Suzuki T, Tanaka A et al (2012) Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancer. Cancer Chemother Pharmacol 70(285–29):1

    Google Scholar 

  5. Carames C, Cristobal I, Moreno V et al (2015) MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer. Int J Colorectal Dis 30:899–906

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Keio University School of Medicine, Tokyo, Japan

    Kohei Shigeta, Hirotoshi Hasegawa, Koji Okabayashi & Yuko Kitagawa

  2. Department of Digestive Surgery, Kitasato University Kitasato Institute Hospital, 9-1 Shirokane 5-Chome, Tokyo, 108-8642, Japan

    Yoshiyuki Ishii

Authors
  1. Kohei Shigeta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshiyuki Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hirotoshi Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Koji Okabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuko Kitagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshiyuki Ishii.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest associated with this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shigeta, K., Ishii, Y., Hasegawa, H. et al. Clinical Usefulness of 5-FU Metabolic Enzymes as Predictive Markers of Response to Chemotherapy in Colorectal Cancer. World J Surg 40, 1019–1020 (2016). https://doi.org/10.1007/s00268-015-3286-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-015-3286-z

Keywords

Search

Navigation